FOLD Stock Summary

• With a one year PEG ratio of 587.47, Amicus Therapeutics Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 92.59% of US stocks.
• With a price/sales ratio of 16.59, Amicus Therapeutics Inc has a higher such ratio than 92.91% of stocks in our set.
• Revenue growth over the past 12 months for Amicus Therapeutics Inc comes in at 117.63%, a number that bests 95% of the US stocks we're tracking.
• Stocks that are quantitatively similar to FOLD, based on their financial statements, market capitalization, and price volatility, are CLVS, LIFE, SILC, SQNS, and XPL.
• FOLD's SEC filings can be seen here. And to visit Amicus Therapeutics Inc's official web site, go to www.amicusrx.com.